15179-5 |
Fibrin D-dimer |
PrThr |
PPP |
Pt |
Ord |
|
|
ACTIVE |
Fibrin D-dimer [Presence] in Platelet poor plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
COAG |
|
15179-5 |
|
|
|
|
Both |
|
|
|
0 |
D Dimer PPP Ql |
|
|
|
|
|
COAGULATION; D Dimer; Dextro; Fragment D-dimer; Hematology; Heme; Ordinal; Plas; Platelet poor plasma; Point in time; PR; QL; Qual; Qualitative; Random; Screen |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
1518-0 |
Glucose^2H post 75 g glucose PO |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHAL.ROUTINE |
|
1518-0 |
|
|
|
|
Both |
|
|
|
0 |
Glucose 2h p 75 g Glc PO SerPl-mCnc |
|
|
|
Y |
|
120 min; 120 minutes; 120min; 2 hours; 2h p 75 g Glc PO; 75Gm; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p 75 g Glc PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders |
2.73 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
Changed Class from "CHAL" to "CHAL.ROUTINE" |
258 |
15180-3 |
Hypochromia |
PrThr |
Bld |
Pt |
Ord |
Automated count |
|
ACTIVE |
Hypochromia [Presence] in Blood by Automated count |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
15180-3 |
|
Automated count |
|
|
Observation |
|
|
|
0 |
Hypochromia Bld Ql Auto |
|
|
|
|
|
Auto; Automated detection; Blood; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Hypochro; Hypochromic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
15181-1 |
IgA |
MCnc |
Body fld |
Pt |
Qn |
|
|
ACTIVE |
IgA [Mass/volume] in Body fluid |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHEM |
|
15181-1 |
|
|
|
|
Both |
|
|
|
0 |
IgA Fld-mCnc |
|
|
|
Y |
|
B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Immune globulin A; Immunoglobulin A; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.73 |
1.0k |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
15182-9 |
IgA |
PrThr |
Ser |
Pt |
Ord |
Immunoelectrophoresis |
|
ACTIVE |
IgA [Presence] in Serum by Immunoelectrophoresis |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
15182-9 |
|
Immunoelectrophoresis |
|
|
Observation |
|
|
|
0 |
IgA Ser Ql IEP |
|
|
|
|
|
Chemistry; IEP; Imm elect; Immune globulin A; Immunoelect; Immunoglobulin A; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SIE; SIEP; SR |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
15183-7 |
IgG |
MCnc |
Body fld |
Pt |
Qn |
|
|
ACTIVE |
IgG [Mass/volume] in Body fluid |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHEM |
|
15183-7 |
|
|
|
|
Both |
|
|
|
0 |
IgG Fld-mCnc |
|
|
|
Y |
|
B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.73 |
1.0k |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
15184-5 |
IgG |
PrThr |
Ser |
Pt |
Ord |
Immunoelectrophoresis |
|
ACTIVE |
IgG [Presence] in Serum by Immunoelectrophoresis |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
15184-5 |
|
Immunoelectrophoresis |
|
|
Observation |
|
|
|
0 |
IgG Ser Ql IEP |
|
|
|
|
|
Chemistry; IEP; Imm elect; Immune globulin G; Immunoelect; Immunoglobulin G; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SIE; SIEP; SR |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
15185-2 |
IgM |
MCnc |
Body fld |
Pt |
Qn |
|
|
ACTIVE |
IgM [Mass/volume] in Body fluid |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHEM |
|
15185-2 |
|
|
|
|
Both |
|
|
|
0 |
IgM Fld-mCnc |
|
|
|
Y |
|
B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Immune globulin M; Immunoglobulin M; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.73 |
1.0k |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
15186-0 |
IgM |
PrThr |
Ser |
Pt |
Ord |
Immunoelectrophoresis |
|
ACTIVE |
IgM [Presence] in Serum by Immunoelectrophoresis |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
15186-0 |
|
Immunoelectrophoresis |
|
|
Observation |
|
|
|
0 |
IgM Ser Ql IEP |
|
|
|
|
|
Chemistry; IEP; Imm elect; Immune globulin M; Immunoelect; Immunoglobulin M; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SIE; SIEP; SR |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
15187-8 |
Immunoglobulin light chains.lambda |
MCnc |
Urine |
24H |
Qn |
|
|
ACTIVE |
Lambda light chains [Mass/volume] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
g/L |
|
|
|
|
|
|
CHEM |
|
15187-8 |
|
|
|
|
Both |
|
|
|
0 |
Lambda LC 24h Ur-mCnc |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Bence Jones protein; BJ Protein; BJP; Chain; Chemistry; Hematology; Heme; Immune globulin; Immuno; Immunoglob; Immunoglobin; Imunoglbon; Imunoglobn; Lambda LC; Level; Mass concentration; QNT; Quan; Quant; Quantitative; UA; UR; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
g/L |
|
|
The LCN was changed from 'Immunoglobulin light chains.lambda' to 'Lambda light chains' for readability. |
0 |
15188-6 |
Immunoglobulin light chains.kappa |
MCnc |
Urine |
24H |
Qn |
|
|
ACTIVE |
Kappa light chains [Mass/volume] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
g/L |
|
|
|
|
|
|
CHEM |
|
15188-6 |
|
|
|
|
Both |
|
|
|
0 |
Kappa LC 24h Ur-mCnc |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Bence Jones protein; BJ Protein; BJP; Chain; Chemistry; Hematology; Heme; Immune globulin; Immuno; Immunoglob; Immunoglobin; Imunoglbon; Imunoglobn; Kappa LC; Level; Mass concentration; QNT; Quan; Quant; Quantitative; UA; UR; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
g/L |
|
|
The LCN was changed from 'Immunoglobulin light chains kappa' to 'Kappa light chains' for better readability. |
0 |
15189-4 |
Immunoglobulin light chains.kappa/Immunoglobulin light chains.lambda |
MRto |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Kappa light chains/Lambda light chains [Mass Ratio] in Serum |
|
MIN |
DefinitionDescription |
|
|
ratio |
|
|
|
|
|
|
CHEM |
|
15189-4 |
|
|
|
|
Observation |
|
|
|
0 |
Kappa LC/Lambda Ser |
|
|
|
Y |
|
Bence Jones protein; BJ Protein; BJP; Chain; Chemistry; Hematology; Heme; Immune globulin; Immuno; Immunoglob; Immunoglobin; Imunoglbon; Imunoglobn; Kappa LC; Lambda LC; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.73 |
1.0k |
|
|
|
|
|
|
|
{ratio} |
|
|
The LCN was changed from 'Immunoglobulin light chains.kappa/Immunoglobulin light chains.lambda' to 'Kappa light chains/Lambda light chains' for readability. |
0 |
1519-8 |
Glucose^2H post 75 g glucose PO |
MCnc |
Ser |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Glucose [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHAL |
|
1519-8 |
|
|
|
|
|
|
|
|
0 |
Deprecated Glucose 2H p 75 g Glc PO Ser- |
|
|
|
|
|
120 min; 120 minutes; 120min; 2 hours; 2h p 75 g Glc PO; 75Gm; After; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p 75 g Glc PO; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.36 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
15190-2 |
Leukocytes other |
Prid |
Bld |
Pt |
Nom |
Automated count |
|
ACTIVE |
Leukocytes other [Identifier] in Blood by Automated count |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
15190-2 |
|
Automated count |
|
|
Observation |
|
|
|
0 |
WBC Other Bld Auto |
|
|
|
|
|
Auto; Automated detection; Blood; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Identity or presence; Leuc; Leuk; Leukocyte; Lkcs; Nominal; Othr; Point in time; Random; WB; WBC; WBC Other; WBCs; White blood cell; White blood cells; Whole blood |
2.07 |
1.0k |
|
|
|
|
|
|
|
|
|
|
|
0 |
15191-0 |
Lupus anticoagulant neutralization.dilute phospholipid |
PrThr |
PPP |
Pt |
Ord |
|
|
DISCOURAGED |
Lupus anticoagulant neutralization dilute phospholipid [Presence] in Platelet poor plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
COAG |
|
15191-0 |
|
|
|
|
Both |
|
|
|
0 |
LA Nt dPL PPP Ql |
|
|
|
|
|
Anticoag; Anti-phospholipid antibody; COAGULATION; Coagulation inhibiting antibody; Dil; Dilut; Dilute prothrombin time; dPT; dRVVT; Hematology; Heme; LA; LA Nt dPL; LAC; Lipid; Lupus inhibitor; Neut; Neutr; Ordinal; Phoslpd; Phospholipids; Pl; Plas; Platelet poor plasma; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue thromboplastin inhibition; TTI; TTIT; UniversalLabOrders |
2.73 |
1.0k |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
15192-8 |
Lymphocytes.variant |
PrThr |
Bld |
Pt |
Ord |
Automated count |
|
ACTIVE |
Variant lymphocytes [Presence] in Blood by Automated count |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
15192-8 |
|
Automated count |
|
|
Observation |
|
|
|
0 |
Variant Lymphs Bld Ql Auto |
|
|
|
|
|
Atypical lymphocytes; Auto; Automated detection; Blood; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Reactive lymphocytes; Screen; Variant lymphocytes; Variant Lymphs; WB; Whole blood |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
15193-6 |
Cells.CD3-CD16+ |
NCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
CD3-CD16+ cells [#/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
/uL |
|
|
|
|
|
|
CELLMARK |
|
15193-6 |
|
|
|
|
Observation |
|
|
|
0 |
CD3-CD16+ Cells # Bld |
|
|
|
Y |
|
#; ABS; absolute; absolutes; Blood; CD3 Cells; CD3+CD16+ Cells; CD3-CD16+ Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; FCGR3A; Leu11; Leu-11; Leu11b; Leu-11B; Leu4; Leu-4; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; T3; WB; Whole blood |
2.42 |
1.0k |
|
|
|
|
|
|
|
/uL |
|
|
|
0 |
15194-4 |
Cells.CD3-CD16+/Cells |
NFr |
Bld |
Pt |
Qn |
|
|
ACTIVE |
CD3-CD16+ cells/cells in Blood |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CELLMARK |
|
15194-4 |
|
|
|
|
Observation |
|
|
|
0 |
CD3-CD16+ Cells NFr Bld |
|
|
|
Y |
|
Blood; CD3 Cells; CD3+CD16+ Cells; CD3-CD16+ Cells; Cell; CELL MARKERS; Cellularity; FCGR3A; Leu11; Leu-11; Leu11b; Leu-11B; Leu4; Leu-4; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T3; WB; Whole blood |
2.79 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
15195-1 |
Cells.CD3-CD19+ |
NCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
CD3-CD19+ cells [#/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
/uL |
|
|
|
|
|
|
CELLMARK |
|
15195-1 |
|
|
|
|
Observation |
|
|
|
0 |
CD3-CD19+ Cells # Bld |
|
|
|
Y |
|
#; ABS; absolute; absolutes; B4; B-4; Blood; CD3 Cells; CD3-CD19+ Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; HD-37; Leu12; Leu-12; Leu4; Leu-4; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; T3; WB; Whole blood |
2.73 |
1.0k |
|
|
|
|
|
|
|
/uL |
|
|
|
0 |
15196-9 |
Cells.CD3-CD19+/Cells |
NFr |
Bld |
Pt |
Qn |
|
|
ACTIVE |
CD3-CD19+ cells/cells in Blood |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CELLMARK |
|
15196-9 |
|
|
|
|
Observation |
|
|
|
0 |
CD3-CD19+ Cells NFr Bld |
|
|
|
Y |
|
B4; B-4; Blood; CD3 Cells; CD3-CD19+ Cells; Cell; CELL MARKERS; Cellularity; HD-37; Leu12; Leu-12; Leu4; Leu-4; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T3; WB; Whole blood |
2.79 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
15197-7 |
Lymphocytes.clefted/Leukocytes |
NFr |
Bld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Lymphocytes clefted/Leukocytes in Blood by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
15197-7 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
Cleft Lymphs NFr Bld Manual |
|
|
|
Y |
|
Blood; Cleaved; Cleft Lymphs; fissured; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphocytes.fissured; Lymphs; Lymphs%; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood |
2.79 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; Previous Releases: Changed Component name 'Lymphocytes.fissured' to the more common name. |
0 |
15198-5 |
Macrocytes |
PrThr |
Bld |
Pt |
Ord |
Automated count |
|
ACTIVE |
Macrocytes [Presence] in Blood by Automated count |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
15198-5 |
|
Automated count |
|
|
Observation |
|
|
|
0 |
Macrocytes Bld Ql Auto |
|
|
|
|
|
Auto; Automated detection; Blood; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Macrocyte; Macrocytosis; Macros; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
15199-3 |
Microcytes |
PrThr |
Bld |
Pt |
Ord |
Automated count |
|
ACTIVE |
Microcytes [Presence] in Blood by Automated count |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
15199-3 |
|
Automated count |
|
|
Observation |
|
|
|
0 |
Microcytes Bld Ql Auto |
|
|
|
|
|
Auto; Automated detection; Blood; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Microcyte; Microcytosis; Micros; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
152-9 |
Cephaloglycin |
Susc |
Isolate |
Pt |
Qn |
MLC |
|
ACTIVE |
Cephaloglycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
152-9 |
|
MLC |
|
|
Observation |
|
|
|
0 |
Cephaloglycin Islt MLC |
|
|
|
Y |
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MBC; Minimum bactericidal concentration; Minimum lethal concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.19 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
1520-6 |
Glucose^2H post 75 g glucose PO |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Mass/volume] in Urine --2 hours post 75 g glucose PO |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHAL |
|
1520-6 |
|
|
|
|
Both |
|
|
|
0 |
Glucose 2h p 75 g Glc PO Ur-mCnc |
|
|
|
Y |
|
120 min; 120 minutes; 120min; 2 hours; 2h p 75 g Glc PO; 75Gm; After; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p 75 g Glc PO; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.73 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |